Patent ID: 8614215

Claim:
A quinoxaline compound according to the following Formula (I) wherein: R 1 is selected from H; or C 1 -C 6 alkyl; R 2 is selected from (CH 2 ) m —R 4 or CO—R 4′ ; R 3 is selected from a C 1 -C 6 alkyl; C 6 -C 18 aryl; or C 3 -C 18 heteroaryl group; wherein aryl and heteroaryl groups may also be substituted with one to five of the following groups: C 1 -C 6 alkyl; C 1 -C 6 alkoxy; NH 2 ; NH—(C 1 -C 6 alkyl); N(C 1 -C 6 alkyl) 2 ; amino (C 1 -C 6 )alkyl; halogen; CN; or C 3 -C 8 heterocycloalkyl; R 4 is selected from hydroxy; C 1 -C 6 alkoxy; C 3 -C 8 cycloalkyl; or C 3 -C 8 heterocycloalkyl in which up to 3 carbon atoms are replaced by heteroatoms selected from O, S, SO 2 or NR, R being selected from a bond to said (CH 2 ) m , group, hydrogen, methyl, acetyl, acyl or sulfone; R 4′ is selected from C 1 -C 6 alkoxy; cycloalkyl; or C 3 -C 8 heterocycloalkyl; m is 1, 2, 3, 4, 5, or 6; or geometrical isomers, enantiomers, diastereomers, tautomers, racemates thereof, and pharmaceutically acceptable salts thereof.